Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Dec 11, 2024 · 10-Q · 41 days after period end · 0001214659-24-020264
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$1.42M | -$2.91M | -$3.11M | -$3.60M |
| EPS Diluted | -$0.40 | -$4.43 | -$0.48 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Oct 31, 2024 · filed Dec 11, 2024 · 41 d after period end
